Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Unit price / market price
-
$0.4006
-
Total 13F principal
-
$236,594,851
-
Principal change
-
-$2,797,313
-
Total reported value
-
$103,500,121
-
Number of holders
-
20
-
Value change
-
-$397,411
-
Number of buys
-
10
-
Number of sells
-
9
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q1 2023
As of 31 Mar 2023 ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 had 20 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $236,594,851 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Pentwater Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., DAVIDSON KEMPNER PARTNERS, DAVIDSON KEMPNER CAPITAL MANAGEMENT LP, WHITEBOX ADVISORS LLC, AMERIPRISE FINANCIAL INC, AGF MANAGEMENT LTD, Affinity Asset Advisors, LLC, and SILVERBACK ASSET MANAGEMENT LLC.
This table shows 20 bond principal holders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.